According to a 2017 report by the Florida Department of Law Enforcement (FDLE), opioids were identified as either the cause of death or were present in the decedent’s system in 5,725 cases in 2016, an increase of 26% over the previous year.
During the 2018 Florida Legislative Session, the Florida Legislature passed opioid reform legislation that will have a significant impact on the practice of medicine in regards to controlled substance prescribing. HB 21 - Controlled Substances went into effect on July 1, 2018.
The legislation has several requirements as described below:
*Legislation Update: HB17, which went into effect on July 1, 2021, authorizes the Florida Board of Podiatric Medicine to require ALL Florida licensed podiatric physicians (not just those registered with the DEA) to complete an approved two-hour continuing education course on safe and effective prescribing of controlled substances as a part of the 40 hours of continuing professional education required for biennial licensure renewal.
To access the FPMA online Prescribing Controlled Substances course, click HERE.
FPMA advises members to avoid attending continuing education courses on prescribing controlled substances that are not offered by a statewide professional association of physicians accredited to provide educational activities and are not approved by the Florida Board of Podiatric Medicine.
Published DEA Guidance